Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

2017

Seven pharma trends for 2017

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …
Feature
novonordiskhq

Fluor wins $2 billion Novo contract to build API manufacturing facility

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fluor, Novo Nordisk, north carolina

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …
News
jj_2johnson_and_johnson

Actelion acquisition hokey-cokey continues with J&J returning to table

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …
News
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …
News
novartis_hq_day

Colombian government forces through near half-price cut of Novartis drug

December 21, 2016 Medical Communications, Sales and Marketing Colombia, Novartis

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …
News
allergan

Allergan shells out $2.9bn for regenerative medicine unit LifeCell

December 21, 2016 Research and Development, Sales and Marketing Allergan, LifeCell, acquisition

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …
News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …
Appointment
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 19, 2016 Manufacturing and Production, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …
News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016 Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …
News
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …
Appointment
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
Feature
fda2outsideweb

FDA orders new label warnings over anaesthetics risk in children

December 19, 2016 Research and Development, Sales and Marketing FDA, anaesthetics

The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …
News
novartis_window

Novartis acquires Ziarco adding to dermatology pipeline

December 19, 2016 Sales and Marketing Novartis, Ziarco, eczema, oral

Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …
News
smoke-1001664_1280

FDA removes black box warning on Pfizer’s anti-smoking medication

December 19, 2016 Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking

The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …
News
1280px-epi-pen_1

Mylan launches $300 generic EpiPen to calm pricing controversy

December 16, 2016 Sales and Marketing Mylan, epipen

Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026